Correlation Between Sinopharm Group and Talanx AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sinopharm Group and Talanx AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinopharm Group and Talanx AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinopharm Group Co and Talanx AG, you can compare the effects of market volatilities on Sinopharm Group and Talanx AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinopharm Group with a short position of Talanx AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinopharm Group and Talanx AG.

Diversification Opportunities for Sinopharm Group and Talanx AG

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sinopharm and Talanx is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Sinopharm Group Co and Talanx AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talanx AG and Sinopharm Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinopharm Group Co are associated (or correlated) with Talanx AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talanx AG has no effect on the direction of Sinopharm Group i.e., Sinopharm Group and Talanx AG go up and down completely randomly.

Pair Corralation between Sinopharm Group and Talanx AG

Assuming the 90 days horizon Sinopharm Group is expected to generate 2.24 times less return on investment than Talanx AG. In addition to that, Sinopharm Group is 1.73 times more volatile than Talanx AG. It trades about 0.09 of its total potential returns per unit of risk. Talanx AG is currently generating about 0.36 per unit of volatility. If you would invest  7,140  in Talanx AG on August 28, 2024 and sell it today you would earn a total of  730.00  from holding Talanx AG or generate 10.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Sinopharm Group Co  vs.  Talanx AG

 Performance 
       Timeline  
Sinopharm Group 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sinopharm Group Co are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sinopharm Group reported solid returns over the last few months and may actually be approaching a breakup point.
Talanx AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Talanx AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Talanx AG is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Sinopharm Group and Talanx AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sinopharm Group and Talanx AG

The main advantage of trading using opposite Sinopharm Group and Talanx AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinopharm Group position performs unexpectedly, Talanx AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talanx AG will offset losses from the drop in Talanx AG's long position.
The idea behind Sinopharm Group Co and Talanx AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Transaction History
View history of all your transactions and understand their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk